无症状成人腹主动脉瘤超声筛查的系统综述
本系统综述为加拿大预防保健工作组制定指南而作,评估超声筛查腹主动脉瘤的获益与危害。基于四项随机对照试验的中等质量证据,男性一次性筛查可显著降低AAA相关死亡率和破裂率,女性筛查无显著获益。
要点
- 65岁以上男性一次性超声筛查可降低AAA相关死亡与破裂。
- 女性一次性AAA筛查未显示显著获益。
- 男性筛查增加AAA相关手术总数,但围手术期死亡率无显著差异。
核心结论
- 对65岁及以上无症状男性进行基于人群的超声AAA筛查可显著降低AAA相关死亡率和破裂率,避免不必要的AAA相关死亡。
- 当前证据显示女性一次性AAA筛查无获益。
- 关于重复筛查及基于危险因素的目标性筛查获益的证据有限。
研究设计与样本
- 系统综述,纳入美国预防服务工作组最新AAA筛查综述中的研究及截至2015年4月检索到的文献(PROSPERO注册号CRD42015019047)。
- 获益分析基于四项随机对照试验的中等质量证据,比较男性一次性AAA筛查与对照。
- 女性证据来自Chichester试验,随访长达10年。
- 危害分析包括男性AAA相关手术总数及30天术后死亡率。
主要发现
- 男性一次性AAA筛查对比对照,随访13至15年,AAA相关死亡率降低42%(RR 0.58;95%CI 0.39-0.88;需筛查人数=212)。
- 男性一次性AAA筛查对比对照,随访13至15年,AAA破裂率降低38%(RR 0.62;95%CI 0.45-0.86;需筛查人数=200)。
- 男性筛查组随访13至15年AAA相关手术总数显著增加,为对照组的2.16倍。
- 女性Chichester试验随访长达10年,筛查组与对照组无显著差异(RR 0.88;95%CI 0.72-1.07)。
- 择期和急诊手术的30天术后死亡率在筛查组与对照组间无显著差异。
临床怎么用
- 可考虑对65岁及以上无症状男性提供一次性超声AAA筛查,以降低AAA相关死亡和破裂。
- 不推荐对女性常规进行一次性AAA筛查,因当前证据未显示获益。
- 重复筛查及基于危险因素的目标性筛查的获益证据有限,需个体化决策。
局限性
- 重复AAA筛查的获益证据有限。
- 基于AAA危险因素的目标性筛查方法的获益证据有限。
- 女性筛查获益证据仅来自Chichester试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This report was produced for the Canadian Task Force on Preventive Health Care to provide guidelines on screening for abdominal aortic aneurysm (AAA) with ultrasound scan. PURPOSE: The aim of this systematic review is to examine the evidence on benefits and harms of AAA screening. SEARCH STRATEGY: This systematic review considered studies from the most recent United States Preventive Services Task Force review on AAA screening and passed through the screening process with citations identified in our search up to April 2015 (PROSPERO Registration #CRD42015019047). RESULTS: For benefits of one-time AAA screening in men compared with controls, pooled analyses from four randomized controlled trials with moderate quality evidence showed significant reductions in AAA-related mortality and AAA rupture rate up to 13 to 15 years of follow-up with 42% reduction (risk ratio [RR], 0.58; 95% confidence interval [CI], 0.39-0.88; number needed to screen = 212) and 38% reduction (RR, 0.62; 95% CI, 0.45-0.86; number needed to screen = 200), respectively. The effect of on all-cause mortality was marginally significant for longer follow-up. The Chichester trial examined the benefits of one-time AAA screening in women and found no significant differences between screening and control arms for up to 10 years of follow-up (RR, 0.88; 95% CI, 0.72-1.07). For consequences of one-time AAA screening in men compared with controls, there was a significant increase in the total number of AAA-related procedures over a follow-up of 13 to 15 years (2.16 times more likely) compared with controls. For harms of one-time AAA screening, no significant differences were observed in 30-day postoperative mortality for elective and emergency operations with compared control groups. Evidence from the Multicenter Aneurysm Screening Study trial using 13-year follow-up data showed that one-time AAA screening with ultrasound scan was potentially associated with an overdiagnosis of 45% (95% CI, 42%-47%) among screen-detected men. CONCLUSIONS: Population-based screening for AAA with ultrasound scan in asymptomatic men aged 65 years and older showed statistically significant reductions in AAA-related mortality and rupture and, hence, avoids unnecessary AAA-related deaths. The current evidence showed no benefit of one-time AAA screening in woman. Limited evidence is available on the benefits of repeat AAA screening and targeted screening approaches based on risk factors for AAA. Future research should explore the differential benefits of AAA screening based on risk factors that increase risk for developing AAA.
引用
- Ali MU, Fitzpatrick-Lewis D, Miller J, et al. Screening for abdominal aortic aneurysm in asymptomatic adults. J Vasc Surg. 2016. PMID: 27871502. doi:10.1016/j.jvs.2016.05.101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。